A single-center experience in use of tocilizumab in COVID-19 pneumonia in India

IL-6 receptor antagonist tocilizumab (TCZ) has been used in several reported studies in the treatment of COVID-19 pneumonia and pieces of evidence are still emerging. All patients with COVID-19 pneumonia showing features of hyperinflammatory syndrome receiving TCZ at a tertiary care center in India...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical journal. Armed Forces India 2021-07, Vol.77 (Suppl 2), p.S296-S304
Hauptverfasser:	Joshi, Aditya, Kumar M, Krishna, Kumar, Abhishek, Nair, Ranjith K., Singh, Jasdeep, Chakrabarti, Ritwik, Kapoor, Rajan
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Hyperinflammatory Interleukin-6 Original Pneumonia Tocilizumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!